ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Other Accumulated Expenses (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) reported Other Accumulated Expenses of $11.84 million for the quarter ended Jun 30, 2026, up 41.2% from $8.38 million a year earlier and up 20.1% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Other Accumulated Expenses (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics posted Other Accumulated Expenses of $8.97 million, down 6.3% from the prior year.

  • Other Accumulated Expenses has a five-year compound annual growth rate of 5.1% (years ended Dec 2020 to Dec 2025).
  • By year, Other Accumulated Expenses came in at $9.58 million in the year ended Dec 31, 2024 (+4.1%), $9.2 million in the year ended Dec 31, 2023 (+0.5%), $9.16 million in the year ended Dec 31, 2022 (-28.1%) and $12.73 million in the year ended Dec 31, 2021 (+82.3%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Other Accumulated Expenses since the quarter ended Sep 30, 2022.
  • Year over year, Other Accumulated Expenses gained in seven of the last eight quarters, with growth averaging 25.7%.
  • The high point for year-over-year Other Accumulated Expenses in five years was the quarter ended Dec 31, 2021 (growth of 68.7%); the low point was the quarter ended Sep 30, 2023 (a decline of 62.1%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $9.86 million (quarter ended Mar 31, 2026), $9.24 million (quarter ended Dec 31, 2025) and $10 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 ProQR Therapeutics 171.74 Mn -291.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.84 Mn
Mar 31, 2026 9.86 Mn
Dec 31, 2025 9.24 Mn
Sep 30, 2025 10.00 Mn
Jun 30, 2025 8.38 Mn
Mar 31, 2025 7.65 Mn
Dec 31, 2024 9.46 Mn
Sep 30, 2024 8.17 Mn
Jun 30, 2024 6.11 Mn
Mar 31, 2024 6.44 Mn
Dec 31, 2023 9.16 Mn
Sep 30, 2023 5.24 Mn
Jun 30, 2023 4.39 Mn
Mar 31, 2023 5.27 Mn
Dec 31, 2022 8.86 Mn
Sep 30, 2022 13.81 Mn
Jun 30, 2022 10.17 Mn
Mar 31, 2022 9.00 Mn
Dec 31, 2021 12.31 Mn
Sep 30, 2021 9.21 Mn
API Access

ProQR Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PRQR&period=max&api_key=YOUR_API_KEY